(Chicago, IL, Monday, June 3, 2019) – Cancer experts from around the world will gather to explore the latest research impacting patient care across the entire cancer care continuum, from prevention and screening to symptom management and survivorship, at the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO).
The 2019 ASCO Annual Meeting, taking place from May 31 to June 4 in Chicago, will bring together nearly 40,000 attendees from across the globe. The theme of this year’s conference is Caring for Every Patient, Learning from Every Patient.
Research to be released at the meeting will shed light on:
- A study looking at the potential impact of new strategies to expand patient eligibility for clinical trials for advanced non-small cell lung cancer;
- A randomized, phase III trial comparing laparoscopic surgery to open surgery in people whose colorectal cancer had metastasized to the liver;
- A randomized, phase III trial exploring maintenance therapy with the PARP inhibitor olaparib among people with pancreatic cancer who had an inherited BRCA gene mutation.
- An analysis of electronic health records looking at the relationship between the Affordable Care Act-related Medicaid expansion and racial disparities in receiving timely cancer treatment; and
- A survey of gynecologic oncologists examining sexual harassment and gender bias.
Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents nearly 45,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net.